The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and tourette's syndrome

References

• Adeloye A., Felson B. Incidence of normal pineal gland calcification in skull roentgenograms of black and white Africans. American Journal of Roentgenology 1974; 122: 503–507
   Web of Science ®Google Scholar
• Ahn H. S., Makman M. H. Serotonin sensitive adenylate cyclase activity in monkey anterior limb cortex: antagonism by molindone and other antipsychotic drugs. Life Sciences 1978; 23: 507–512
   PubMed Web of Science ®Google Scholar
• Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Altamura A. C., Mauri M. C., Mantero M., Brunetti M. Clonazepam/haloperidol combination therapy in schizophrenia: a double blind study. Acta Psychiatrica Scandinavica 1987; 76: 702–706
   PubMed Web of Science ®Google Scholar
• Altschule M. D. Some effects of aqueous extracts of acetone extracts of acetone dried beef pineal substance in chronic schizophrenia. New England Journal of Medicine 1957; 257: 919–922
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (3rd. ed.). Washington, DC. 1980
   Google Scholar
• Anton-Tay F., Chou C, Anton S., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Anton-Tay F. Melatonin: effects on brain function. Advances in Biochemical Psychopharmacology 1974; 11: 315–324
   PubMedGoogle Scholar
• Bacopoulos N. G. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies. Journal of Pharmacology and Experimental Therapeutics 1981; 219: 708–714
   PubMed Web of Science ®Google Scholar
• Balsara J. J., Jadhav J. H., Muley M. P., Chandorkar A. C. Effects of drugs influencing central serotonergic mechanisms on methamphetamine-induced stereotyped behavior in the rat. Psycho-pharmacology 1979; 64: 303–308
   PubMed Web of Science ®Google Scholar
• Bar-or A., Brown G. M. Pineal involvement in the diurnal rhythm of nociception in the rat. Life Sciences 1989; 44: 1067–1075
   PubMed Web of Science ®Google Scholar
• Bedard P. J., Langelier P., Dankova J. Estrogens, progesterone, and the extrapyramidal system. Advances in Neurology, L. J. Poirier, T. L. Sourkes, P. J. Bedard. Raven Press, New York 1979; 24: 411–422
   Google Scholar
• Bennett J. P., Enna S. J., Bylund D., Gillin J. C., Wyatt R. J., Snyder S. H. Neurotransmitter receptors in frontal cortex of schizophrenics. Archives of General Psychiatry 1979; 36: 927–934
   PubMed Web of Science ®Google Scholar
• Bigelow L., Walls P., Gillin J. C., Wyatt R. J. Clinical effects of I-5-hydroxytryptophan administration in chronic schizophrenic patients. Biological Psychiatry 1979; 14: 53–67
   PubMed Web of Science ®Google Scholar
• Blelch A., Bernout E., Apter A. Gilles de la Tourette syndrome and mania in an adolescent. British Journal of Psychiatry 1985; 146: 664–665
   PubMed Web of Science ®Google Scholar
• Bobillier P., Seguin S., Petitjean F., Salvert D., Jouvet M, Jouvet M. The raphe nuclei of the cat brainstem: A topographical atlas of their efferent projections as revealed by autoradiography. Brain Research 1976; 113: 449–457
   PubMed Web of Science ®Google Scholar
• Bobruff A., Gardos G., Tarsy D., Rapkin R. M., Cole J. O., Moore P. Clonazepam and phenobarbital in tardive dyskinesia. American Journal of Psychiatry 1981; 2: 189–193
   Google Scholar
• Boyce P. M. 6-sulphatoxymelatonin in melancholia. American Journal of Psychiatry 1985; 142: 125–127
   PubMed Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the midbrain can regulate forebrain dopamine function both behaviourally and biochemically. Advances in biosciences: The pineal gland: Endocrine Aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, New York 1985; 327–332
   Google Scholar
• Brown G. M., Young S. N., Gauthier S., Tsui H., Grota L. J. Melatonin in human cerebrospinal fluid in daytime: its origin and variation with age. Life Sciences 1979; 25: 929–936
   PubMed Web of Science ®Google Scholar
• Brown R., Kocsis J. H., Caroff S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Bruun R. D. Gilles de la Tourette's syndrome. An overview of clinical experience. Journal of the American Academy of Child Psychiatry 1984; 23: 126–133
   PubMedGoogle Scholar
• Burd L., Kerbeshian J. Tourette syndrome and bipolar disorder. Archives of Neurology 1984; 41: 1236
   PubMedGoogle Scholar
• Caine E. D. Gilles de la Tourette's syndrome: a review of clinical and research studies and consideration of future directions for investigation. Archives of Neurology 1985; 42: 393–397
   PubMedGoogle Scholar
• Carlsson M., Svensson K., Eriksson E., Carlsson A. Rat brain serotonin: Biochemical and functional evidence for a sex difference. Journal of Neural Transmission 1985; 63: 297–313
   PubMed Web of Science ®Google Scholar
• Carter C. J., Pycock C. J. Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats. British Journal of Pharmacology 1977; 60: 267–271
   Web of Science ®Google Scholar
• Casey D. E. Tardive dyskinesia: Reversible and irreversible. Dyskinesia: research and treatment, D. E. Casey, T. N. Chase, A. V. Christensen. Springer Verlag, Berlin 1985; 88–97
   Google Scholar
• Chase T. N., Schnur J. A., Gordon E. K. Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacology 1970; 9: 265–268
   PubMed Web of Science ®Google Scholar
• Chase T. N., Ng L. K. Y., Watanabe A. M. Parkinson's disease: modification by 5-hydroxy-tryptophan. Neurology 1972; 22: 479–482
   PubMed Web of Science ®Google Scholar
• Chiba M., Yamada M. About calcification of pineal gland in Japanese. Folia Psychiatrica and Neurologica Japonica 1948; 2: 301–303
   Google Scholar
• Chouinard G., Annable L., Ross-Chouinard A., Nestoros J. N. Factors related to tarive dyskinesia. American Journal of Psychiatry 1979; 136: 79–83
   PubMed Web of Science ®Google Scholar
• Cohen H. N., Hay I. D., Annesley T. M., Beastall G. H., Wallace A. M., Spooner R., Thomson J. A., Eastwood P., Klee G. G. Serum immunoreactive melatonin in boys with delayed puberty. Clinical Endocrinology 1982; 17: 517–521
   PubMed Web of Science ®Google Scholar
• Comings B. G., Comings D. E. A controlled study of Tourette syndrome. V: Depression and mania. American Journal of Human Genetics 1987; 41: 804–821
   PubMed Web of Science ®Google Scholar
• Costall B., Fortune D., Naylor R. J., Marsden C. C., Pycock C. J. Serotonergic involvement with neuroleptic catalepsy. Neuropharmacology 1975; 14: 859–864
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movements induced by L-dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Crane G. Dyskinesia and neuroleptics. Archives of General Psychiatry 1968; 19: 700–703
   PubMed Web of Science ®Google Scholar
• Cremer-Bartels G., Kaufmann F., Kuchle H. J. Wirkung von Chlorpromazin auf die Biosynthese von Melatonin in der Netzhaut. Fortschritte der Opthalmologie 1983a; 79: 470–472
   PubMedGoogle Scholar
• Cremer-Bartels G., Ebels I., Sykes J. E. C., De Moree A. Effects of retinal and pineal low molecular weight fractions and antipsychotic drugs on hydroxyindole-O-methyltransferase. Journal of Neural Transmission 1983b; 58: 107–119
   PubMed Web of Science ®Google Scholar
• Cutler N., Post R., Rey A., Bunney W. Depression-dependent dyskinesias in two cases of manic depressive illness. New England Journal of Medicine 1981; 304: 1088–1089
   PubMed Web of Science ®Google Scholar
• Datta P. C., King M. G. Melatonin; Effects on brain and behavior. Neuroscience & Biobehavioral Reviews 1978; 4: 451–458
   Web of Science ®Google Scholar
• Dax E. M., Sugden D. Age-associated changes in pineal adrenergic receptors and melatonin synthesising enzymes in the Wistar rat. Journal of Neurochemistry 1988; 50: 468–472
   PubMed Web of Science ®Google Scholar
• De Potter R. W., Linkowski P., Mendelewicz J. State-dependent tardive dyskinesia in manic-depressive illness. Journal of Neurology Neurosurgery and Psychiatry 1983; 46: 666–668
   PubMed Web of Science ®Google Scholar
• Dyke C. G. Indirect signs of brain tumor as noted in routine roentgen examinations: displacement of pineal shadow: survey of 3000 consecutive skull examinations. American Journal of Roentgenology & Radiation Therapy 1930; 23: 598–606
   Google Scholar
• Erenberg G., Cruse R. P., Rothner A. D. The natural history of Tourette syndrome: A follow-up study. Annals of Neurology 1987; 22: 383–385
   PubMed Web of Science ®Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal glands; anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Fanget F., Claustrat B., Dalery J., Brun J., Terra J. L. Nocturnal plasma melatonin levels in schizophrenic patients. Biological Psychiatry 1989; 25: 499–501
   PubMed Web of Science ®Google Scholar
• Fernando S. J. M. Gilles de la Tourelte's syndrome: A report on four cases and a review of published case reports. British Journal of Psychiatry 1967; 113: 607–617
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Arendt J., Johnstone E. C., Crow T. J. Reduced nocturnal melatonin secretion in chronic schizophrenia: Relationship to body weight. Clinical Endocrinology 1982; 17: 181–187
   PubMed Web of Science ®Google Scholar
• Fibiger H. C., Lloyd K. G. Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. Trends in Neuroscience 1984; 7: 462–464
   Web of Science ®Google Scholar
• Fleischhauer J., Kocher R., Hobi V., Gilsdorf U. Prevalence of tardive dyskinesia in a clinic population. Dyskinesia: research and treatment, D. E. Casey, T. N. Chase, A. V. Christensen, J. Gerlach. Springer-Verlag, Berlin 1985; 162–172
   Google Scholar
• Fog R., Pakkenberg H., Regeur L., Pakkenberg B. “Tardive” Tourette syndrome in relation to long-term neuroleptic treatment of multiple tics. Gilles de la Tourette syndrome, A. J. Friedhoff, T. N. Chase. Raven Press, New York 1982; 419–421
   Google Scholar
• Gaddum J. H. Drugs antagonistic to 5-hydroxytryptamine. Ciba Foundation Symposium on Hypertension, G. W. Wolstenholme. Little Brown and Company, Boston 1954; 75–77
   Google Scholar
• Gaffori O., Geffard M., Van Ree J. M. des-Tyr1-gamma-endorphin and haloperdiol increase pineal gland melatonin levels in rats. Peptides 1983; 4: 393–395
   PubMed Web of Science ®Google Scholar
• Gaffori O., Van Ree J. M. Serotonin and antidepressant drugs antagonize melatonin-induced behavioral changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985; 24: 237–244
   PubMed Web of Science ®Google Scholar
• Gey K. F., Georgi H. Effect of neuroleptic drugs on total pyridoxal phosphate and on the activity of the decarboxylase of arimatic amino acids as well as of other pyridoxal phosphate-dependent enzymes in the rat brain. Journal of Neurochemistry 1974; 23: 725–738
   PubMed Web of Science ®Google Scholar
• Gimenez-Roldan S., Mateo D., Bartolome P. Tardive dystonia and severe tardive dyskinesia: a comparison of risk factors and prognosis. Acta Psychiatrica Scandinavica 1985; 71: 488–494
   PubMed Web of Science ®Google Scholar
• Goetz C. G. Tics: Gilles de la Tourette's syndrome. Handbook of clinical neurology, vol. 5: extrapyramidal disorders, P. J. Vinken, G. W. Bruyn, H. L. Klawans. Elsevier Publishers, Amsterdam 1986; 627–639
   Google Scholar
• Haber S. N., Kowall N. W., Vonsattel J. P., Bird E. D., Richardson E. P. Gilles de la Tourette's syndrome: A postmortem neuropathological and immunohistochemical study. Journal of the Neurological Sciences 1986; 75: 225–241
   PubMed Web of Science ®Google Scholar
• Hamra B. J., Nasrallah H. A., Clancy J., Finn R. Psychiatric diagnosis and risk of tardive dyskinesia. Archives of General Psychiatry 1983a; 40: 346–347
   PubMed Web of Science ®Google Scholar
• Hamra B. J., Dunner F. H., Larson C. Remission of tics with lithium therapy: Case report. Journal of Clinical Psychiatry 1983b; 44: 74–74
   PubMed Web of Science ®Google Scholar
• Hanssen T., Heyden T., Sundberg J., Alfredsson G., Nyback H., Wetterberg L. Propranolol in schizophrenia: clinical, metabolic and pharmacological findings. Archives of General Psychiatry 1980; 37: 685–689
   PubMed Web of Science ®Google Scholar
• Hardy M., LeCrubier V., Widlocher D. Efficacy of clonidine in 24 patients with acute mania. American Journal of Psychiatry 1986; 143: 1450–1453
   PubMed Web of Science ®Google Scholar
• Hartley R., Padwick D., Smith J. A. The inhibition of pineal hydroxyindole-o-methyltrans-ferase by haloperidol and fluphenazine. Journal of Pharmacology & Pharmacy 1972; 24: 100P–103P, suppl
   Web of Science ®Google Scholar
• Hartley R., Smith J. A. The activation of pineal hydroxyindole-O-methyltransferase by psycho-mimetic drugs. Journal of Pharmacology & Pharmacy 1973; 25: 751–752
   PubMed Web of Science ®Google Scholar
• Horita N., Ishii T., Moroji T. Effects of long-term administration of Chlopromazine on the pineal gland of rats. Acta Neuropathologica 1978; 42: 49–52
   PubMed Web of Science ®Google Scholar
• Horrobin D. F. Schizophrenia: reconciliation of the dopamine prostaglandin, and opioid concepts and the role of the pineal. Lancet 1979; 1: 529–530
   PubMed Web of Science ®Google Scholar
• Houssay A. B., Barcelo A. C. Effects of estrogens and progesterone upon the biosynthesis of melatonin by the pineal gland. Experientia 1972; 24: 478–479
   Google Scholar
• Jagger J., Prusoff B. A., Cohen D. J., Kidd K. K., Carbonari C. M., John K. The epidemiology of Tourette's syndrome: A pilot study. Schizophrenia Bulletin 1982; 8: 267–278
   PubMed Web of Science ®Google Scholar
• Jankovic J., Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette's syndrome. Canadian Journal of Neurological Sciences 1987; 14: 541–546
   PubMed Web of Science ®Google Scholar
• Jeste D. V., Wyatt R. J. Dogma disputed: Is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity. Journal of Clinical Psychiatry 1981; 42: 455–457
   PubMed Web of Science ®Google Scholar
• Jus A., Pineau R., Lachance R., Pelchat G., Jus K., Pires P., Villeneuve R. Epidemiology of tardive dyskinesia. Part I. Diseases of the nervous system 1976; 37: 210–214
   PubMedGoogle Scholar
• Kamberi I. A., Michal R. S., Porter J. C. Effects of melatonin and serotonin on FSH and prolactin. Endocrinology 1971; 88: 1288–1295
   PubMed Web of Science ®Google Scholar
• Kane J. M., Woerner M., Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. Journal of Clinical Psychopharmacology 1988; 8: 52S–56S, (suppl)
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Redding T. W., Schally A. V. MSH activity in rat pituitaries after pinealectomy. Proceeding of the Society of Experimental Biology and Medicine 1967; 124: 1275–1277
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Hirst M., Teskey G. C. Ageing, opioid analgesia and the pineal gland. Life Sciences 1983; 32: 2279–2287
   PubMed Web of Science ®Google Scholar
• Kerbeshian J., Burd L. Tourette disorder and bipolar symptomatology in childhood and adolescence. Canadian Journal of Psychiatry 1989; 34: 230–233
   PubMed Web of Science ®Google Scholar
• King R., Faull K. F., Stahl S. M., Mefford I. N., Thiemann S., Barchas J., Berger P. A. Serotonin and schizophrenia: correlations between serotonergic activity and schizophrenic motor behavior. Psychiatry Research 1985; 14: 235–240
   PubMed Web of Science ®Google Scholar
• Kitay J. I. Pineal lesions and precocious puberty: a review. Journal of Clinical Endocrinology and Metabolism 1954; 14: 622–625
   PubMed Web of Science ®Google Scholar
• Klawans H. L. The pharmacology of tardive dyskinesia. American Journal of Psychiatry 1973; 130: 82–86
   PubMed Web of Science ®Google Scholar
• Klein D. C. Pineal gland as a model of neuroendocrine control systems. The hypothalamus, S. Reichlin, R. J. Baldessarini, J. B. Martin. Raven Press, New York 1987; vol. 56: 327
   Google Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Korsgaard S., Gerlach J., Christensson E. Behavioral aspects of serotonin-dopamine interaction in the monkey. European Journal of Pharmacology 1985; 118: 245–252
   PubMed Web of Science ®Google Scholar
• Koulu M., Lammintausta R. Effect of melatonin on L-tryptophan and apomorphine stimulated growth hormone secretion in man. Journal of Endocrinology and Metabolism 1979; 49: 70–72
   Google Scholar
• Kozell L., Sandyk R., Wagner G. C., Fisher H. The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. Life Sciences 1987; 41: 1739–1744
   PubMed Web of Science ®Google Scholar
• Kumar M. S. A., Chen C. L., Sharp D. C., Liu J. M., Kalra P. S., Kalra S. P. Diurnal fluctuations in methionine-enkephalin levels in the hypothalamus and preoptic area of the male rat: effects of pinealectomy. Neuroendocrinology 1982; 35: 28–31
   PubMed Web of Science ®Google Scholar
• Lakke J. P. W. F., Wilmink J. T. A case of Gilles de la Tourette's syndrome with midbrain involvement. Journal of Neurology, Neurosurgery, and Psychiatry 1985; 48: 1293–1296
   PubMed Web of Science ®Google Scholar
• Lakin M. L., Miller C. H., Stratt M. L., Winters W. D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sciences 1981; 29: 2543–2551
   PubMed Web of Science ®Google Scholar
• Lal K. P., Saxena S., Mohan D. Tardive dystonia alternating with mania. Biological Psychiatry 1988; 23: 312–316
   PubMed Web of Science ®Google Scholar
• Leckman J. F., Cohen D. J. Recent advances in Gilles de la Tourette's syndrome: Implications for clinical practice and future research. Psychiatric Developments 1983; 3: 301–316
   Google Scholar
• Lewy A. J., Wehr T. A., Gold P. W., Goodwin F. K. Plasma melatonin in manic-depressive illness. Catecholamines: basic and clinical frontiers, E. Usdin, I. J. Kopin, J. Barchas. Pergamon Press, Oxford 1979; vol. II: 1173–1175
   Google Scholar
• Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D., Rosenthal N. E. Manic-depressive patients may be supersensitive to light. Lancet 1981; 1: 383–384
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Kern H. A. Human melatonin secretion: A marker of the circadian system and the effects of light. Neurobiology of mood disorders, R. N. Post, J. C. Ballender. William & Wilkins, Baltimore 1984; 215–226
   Google Scholar
• Lewy A. J., Nurnberger J. I., Wehr T. A., Pack D., Becker L. E., Powell R. L., Newsome D. A. Supersensitivity to light: Possible trait marker for manic-depressive illness. American Journal of Psychiatry 1985; 142: 725–727
   PubMed Web of Science ®Google Scholar
• Leysen J. E., Niemegeers C. J. E., Tollenaere J. P., Laduron P. M. Serotonergic component of neuroleptic receptors. Nature 1978; 272: 168–171
   PubMed Web of Science ®Google Scholar
• Lissoni P., Espositi P., Espositi G., Mauri R., Resentini M., Morabito F., Fumagalli P., Santagostino A., Delitala G., Fraschini F. A clinical study on the relationship between the pineal gland and the opioid system. Journal of Neural Transmission 1986; 65: 63–73
   PubMed Web of Science ®Google Scholar
• Lynch H. J., Wang P., Wurtman R. J. Increase in rat pineal melatonin content following L-dopa administration. Life Sciences 1973; 12: 145–151
   Web of Science ®Google Scholar
• MacKay R. T. Pineal calcification in Indians and Fijians. Royal Society of Tropical Medicine and Hygiene 1973; 67: 214–216
   Google Scholar
• Macpherson P., Matheson M. S. Comparison of calcification of pineal, habenular commisure and choroid plexus on plain films and computed tomography. Neuroradiology 1979; 18: 67–72
   PubMed Web of Science ®Google Scholar
• Maestroni G. I. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 277–279
   Google Scholar
• Marsden C. D., Tarsy D., Baldessarini R. J. Spontaneous and drug-induced movement disorders in psychotic patients. Psychiatric aspects of neurologic disease, D. F. Benson, D. Blumer. Grune & Stratton, New York 1975; 219–266
   Google Scholar
• Marsden C. D., Jenner P. The pathophyysiology of extrapyramidal side-effects of neuroleptic drugs. Psychological Medicine 1980; 10: 55–72
   PubMed Web of Science ®Google Scholar
• McEachron E., Kripke D., Hawkins R., Haus R., Parlinac D., Deftos L. Lithium delays biochemical circadian rhythms in rats. Neuropsychobiology 1982; 8: 12–29
   PubMed Web of Science ®Google Scholar
• McLsaac W. M. A biochemical concept of mental disease. Postgraduate Medicine 1961; 30: 111–118
   PubMed Web of Science ®Google Scholar
• Meek J. L., Bertilsson L., Cheney D. L., Zsilla G., Costa E. Aging-induced changes in acetylcholine and serotonin content of discrete brain nuclei. Journal of Gerontology 1977; 32: 129–131
   Google Scholar
• Meltzer H. Y. Biological studies in schizophrenia. Schizophrenia Bulletin 1987; 13: 77–111
   PubMed Web of Science ®Google Scholar
• Mendlewicz J., Linkowski P., Branchey L., Weinberg U., Weitzman E. D., Branchey M. Abnormal 24 hour pattern of melatonin secretion in depression. Lancet 1979; 2: 1361
   Web of Science ®Google Scholar
• Messiha F. S., Carlson J. C. Behavioral and clinical profiles of Tourette's syndrome: A comprehensive overview. Brain Research Bulletin 1983; 11: 195–204
   PubMed Web of Science ®Google Scholar
• Miles A., Philbrick D. R. S. Melatonin and psychiatry. Biological Psychiatry 1988; 23: 405–425
   PubMed Web of Science ®Google Scholar
• Mita T., Hanada S., Nishino N., Kuno T., Nakai H., Yamadori T., Mitzol Y., Tanaka C. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biological Psychiatry 1986; 21: 1407–1414
   PubMed Web of Science ®Google Scholar
• Morganini J. B. The seats and causes of diseases: investigated by anatomy, Alexander Benjamin. Millar & Cadell, London 1769
   Google Scholar
• Mukherjee S., Rosen A. M., Caracci G., Shukla S. Persistent tardive dyskinesia in bipolar patients. Archives of General Psychiatry 1986; 43: 342–346
   PubMed Web of Science ®Google Scholar
• Mukherjee S., Roth S., Sandyk R., Schnur D. B. Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance. Psychiatry Research 1989; 29: 17–27
   PubMed Web of Science ®Google Scholar
• Myer E. C., Tripathi H. L., Dewey W. L. Hyperendorphinism: Results and treatment in movement disorders. Annals of Neurology 1989; 26: 446–447
   Web of Science ®Google Scholar
• Namboodiri M. A. A., Sugden D., Klein D. C. 5-hydroxytryptophan elevates serum melatonin. Science 1983; 162: 277–278
   Google Scholar
• Naylor R. J., Olley J. E. The distribution of haloperidol in rat brain. British Journal of Pharmacology 1969; 36: 208P–209P
   Web of Science ®Google Scholar
• Nieto A., Nieto D. The red nucleus, the substantia nigra and the pineal gland responsible for mental illness. International Journal of Neuroscience 1987; 32: 277–278
   Web of Science ®Google Scholar
• Nir 1., Hirschmann N., Sulman F. G. Inhibition of pineal HIOMT by pyridoxal phosphate. Biochemical Pharmacology 1976; 25: 581–583
   PubMed Web of Science ®Google Scholar
• Ogle C. (1898). Melanotic sarcoma of the pineal body. British Medical Journal, 2: 1745
   Google Scholar
• Owen F., Ferrier I. N., Poulter M., Crow T. J. Hydroxy-indole-o-methyltransferase activity in human pineals: A comparison of controls and schizophrenics. Clinical Endocrinology 1983; 19: 313–317
   PubMed Web of Science ®Google Scholar
• Pauls D. L., Leckman J. F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. New England Journal of Medicine 1986; 315: 993–997
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Snyder S. H. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. American Journal of Psychiatry 1980; 137: 1518–1522
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Lebovitz R. M., Snyder S. H. Two distinct central serotonin receptors with different physiological functions. Science 1981; 212: 827–829
   PubMed Web of Science ®Google Scholar
• Reiter R. J., Rollag M. D., Panke E. S., Banks A. F. Melatonin: reproductive effects. Journal of Neural Transmission 1978; 13: 209–223, (suppl)
   Google Scholar
• Reiter R. J. The pineal gland and its hormones in the control of reproduction in mammals. Endocrine Reviews 1980; 1: 109–131
   PubMedGoogle Scholar
• Reiter R. J., Craft C. M., Johnson J. E., King T. S., Richardson B. A., Vaughan T. M., Vaughan M. K. Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology 1980a; 109: 1295–1297
   Web of Science ®Google Scholar
• Reiter R. J., Richardson B. A., Johnson L. Y., Ferguson B. N., Dinh D. T. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 1980b; 210: 1372–1373
   PubMed Web of Science ®Google Scholar
• Reiter R. J. The mammalian pineal gland: structure and function. American Journal of Anatomy 1981; 162: 287–313
   PubMedGoogle Scholar
• Rosenstein R. E., Cardinali D. P. Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Research 1986; 398: 403–406
   PubMed Web of Science ®Google Scholar
• Rosenthal N. E., Sack D. A., James S. H., Barbara L. P., Mendelson W. B., Tamarkin L., Wehr T. A. Seasonal affective disorder and phototherapy. Annals of the New York Academy of Science 1986; 453: 260–269
   Web of Science ®Google Scholar
• Rush M., Diamond F., Alpert M. Depression as a risk factor in tardive dyskinesia. Biological Psychiatry 1982; 17: 387–392
   PubMed Web of Science ®Google Scholar
• Ruzsas C. Functional relationships between pineal gland and habenular complex. Fundamentals and clinics in pineal research, G. P. Trentini, C. DeGaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 257–270
   Google Scholar
• Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M., Singer C. M. Human melatonin production decreases with age. Journal of Pineal Research 1986; 3: 379–388
   PubMed Web of Science ®Google Scholar
• Sandyk R. The effects of naloxone in Tourette's syndrome. Annals of Neurology 1985; 18: 367
   PubMed Web of Science ®Google Scholar
• Sandyk R. Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome. International Journal of Neuroscience 1988; 43: 107–110
   PubMed Web of Science ®Google Scholar
• Sandyk R. Alpha-melanocyte stimulating hormone (MSH) in Tourette's syndrome. International Journal of Neuroscience 1989a; 44: 161–164
   PubMed Web of Science ®Google Scholar
• Sandyk R. Abnormal opiate receptor functions in Tourette's syndrome. International Journal of Neuroscience 1989a; 44: 209–214
   PubMed Web of Science ®Google Scholar
• Sandyk R. Melatonin, sex steroids, and opioid peptide interactions in tardive dyskinesia. International Journal of Neuroscience 1989c; 48: 317–320
   PubMed Web of Science ®Google Scholar
• Sandyk R. Tardive dyskinesia associated with depression in a bipolar disorder patient: Possible role of pineal melatonin. International Journal of Neuroscience 1990a; 52: 79–83
   PubMed Web of Science ®Google Scholar
• Sandyk R. Pineal melatonin functions: Possible relevance to Parkinson's disease. International Journal of Neuroscience 1990b; 50: 37–53
   PubMed Web of Science ®Google Scholar
• Sandyk R. Pineal melatonin functions and the depression of Parkinson's disease. International Journal of Neuroscience 1990c; 51: 73–77
   PubMed Web of Science ®Google Scholar
• Sandyk R. The relationship of pineal calcification to tardive dyskinesia. International Journal of Neuroscience 1990d; 52: 103–105
   PubMed Web of Science ®Google Scholar
• Sandyk R., Allender J. Brain reward systems in Tourette's syndrome. International Journal of Neuroscience 1989; 45: 255–257
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R. Fluctuations of symptoms during manic-depressive mood changes in Tourette's syndrome. Journal of Clinical Psychopharmacology 1988a; 8: 149
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R. Gilles de la Tourette syndrome associated with chronic schizophrenia. International Journal of Neuroscience 1988a; 41: 83–86
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Binkiewicz A., Finley P. R. Gonadotrophin deficiency in Tourette's syndrome: A preliminary communication. International Journal of Neuroscience 1988; 42: 121–125
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Fisher H. Efficacy of L-tryptophan in neuroleptic-induced tardive dyskinesia. Neurology 1988; 38: 128, (suppl 1)
   Google Scholar
• Sandyk R., Consroe P., Iacono R. P. L-tryptophan in drug-induced movement disorder with insomnia. New England Journal of Medicine 1987; 314: 1257
   Web of Science ®Google Scholar
• Sandyk R., Fisher H. Serotonin in movement disorders. International Journal of Neuroscience 1988; 42: 185–205
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. The protective role of the pineal gland in tardive dyskinesia. International Journal of Neuroscience 1988; 43: 215–218
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence and severity of neuroleptic-induced movement disorder in pinealectomized rats. International Journal of Neuroscience 1989a; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. Journal of Clinical Psychopharmacology 1989a; 9: 147–148
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Treatment with p-chloroamphetamine enhances the development of neurleptic-induced orofacial dyskinesias in the rat. International Journal of Neuroscience 1989c; 48: 129–131
   PubMed Web of Science ®Google Scholar
• Sandyk R., Gillman M. A. Gilles de la Tourette's syndrome: effect of analgesic concentration of nitrous oxide. British Medical Journal 1984; 288: 114
   PubMedGoogle Scholar
• Sandyk R., Gillman M. A. The opioid system in Tourette's syndrome. Psychiatry Research 1985; 15: 161–162
   PubMed Web of Science ®Google Scholar
• Sandyk R., Kay S. R. The significance of pineal calcification for prefrontal cortical atrophy in chronic schizophrenia. International Journal of Neuroscience., in press a
   Google Scholar
• Sandyk R., Kay S. R. Drug-induced Parkinsonism is related to pineal gland calcification. International Journal of Neuroscience., in press b
   Google Scholar
• Sandyk R., Kay S. R. The role of pineal melatonin functions in the pathophysiology of schizophrenia: A review and hypothesis. Schizophrenia Bulletin., in press c
   Google Scholar
• Sandyk R., Kay S. R. The relationship of negative schizophrenia to Parkinsonism. International Journal of Neuroscience., in press d
   Web of Science ®Google Scholar
• Sandyk R., Kay S. R. Melatonin secretion and the pathophysiology of Meige's disease (idiopathic orofacial dystonia): A hypothesis. Functional Neurology., in press e
   Google Scholar
• Sandyk R., Mukherjee S. Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system. International Journal of Neuroscience 1989; 48: 297–301
   PubMed Web of Science ®Google Scholar
• Sandyk R., Pardeshi R. Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: Possible role of melatonin. International Journal of Neuroscience., in press
   Web of Science ®Google Scholar
• Schachter M., Geaney D. P., Grahame-Smith D. G., Cowen P. J., Elliott J. M. Increased platelet membrane 3H-LSD binding in patients on chronic neuroleptic treatment. British Journal of Clinical Pharmacology 1985; 19: 453–457
   PubMed Web of Science ®Google Scholar
• Schooler N. R., Kane J. M. Research diagnoses of tardive dyskinesia. Archives of General Psychiatry 1982; 39: 486–487
   PubMed Web of Science ®Google Scholar
• Shih J. C., Young H. The alteration of serotonin binding sites in aged human brain. Life Sciences 1978; 23: 1441–1448
   PubMed Web of Science ®Google Scholar
• Silman R. E., Leone R. M., Hooper R. J. L., Preece M. A. Melatonin, the pineal gland and human puberty. Nature 1979; 282: 301–303
   PubMed Web of Science ®Google Scholar
• Simpson G., Lee J., Zoubok B., Cole J. O., Gardos G. A rating scale for tardive dyskinesia. Psychopharmacology 1979; 64: 171–179
   PubMed Web of Science ®Google Scholar
• Singer H. S., Butler I. J., Tune L. E., Seifert W. E., Coyle J. T. Dopaminergic dysfunction in Tourette syndrome. Annals of Neurology 1982; 12: 361–366
   PubMed Web of Science ®Google Scholar
• Small J. G., Milstein V., Marhenke J. D., Hall D. D., Kellams J. J. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity and treatment resistant psychosis. Journal of Clinical Psychiatry 1987; 48: 263–267
   PubMed Web of Science ®Google Scholar
• Smith J. A., Mee T. J. X., Barnes J. L. C. Elevated melatonin serum concentrations in psychiatric patients treated with chlorpromazine. Journal of Pharmacology & Pharmacy 1977; 29: 30P
   PubMed Web of Science ®Google Scholar
• Smith J. M., Baldessarini R. J. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Archives of General Psychiatry 1980; 37: 1368–1373
   PubMed Web of Science ®Google Scholar
• Smith J. A., Mee T. J. X., Padwick D. J., Spokes E. G. Human post-mortem pineal enzyme activity. Clinical Endocrinology 1981; 14: 75–81
   PubMed Web of Science ®Google Scholar
• Souetre E., Salvati E., Belugou J. L., Robert P., Brunet G., Darcourt G. Antidepressant effect of 5-methoxypsoralen: A preliminary report. Psychopharmacology 1988; 95: 430–431
   PubMed Web of Science ®Google Scholar
• Sugden D., Morris R. D. Changes in regional brain levels of tryptophan, 5-hydroxytryptamine, 5-hydroxyindoleaceticacid, dopamine and noradrenaline after pinealectomy. Journal of Neurochemistry 1979; 32: 1593–1594
   PubMed Web of Science ®Google Scholar
• Sutcher H. D., Underwood R. G., Beatty R. V., Sugar O. Orofacial dyskinesia: a dental dimension. Journal of the American Medical Association 1971; 216: 1459–1463
   Web of Science ®Google Scholar
• Takeuchi K., Yamashita M., Morikiyo M., Takeda N., Morita K., Tamura T., Kaiya H. Gilles de la Tourette syndrome and schizophrenia. The Journal of Nervous and Mental Disease 1986; 174: 247–248
   PubMed Web of Science ®Google Scholar
• Tapp E., Huxley M. The weight and degree of calcification of the pineal gland. Journal of Pathology 1971; 105: 31–39
   PubMed Web of Science ®Google Scholar
• Tapp E. The histology and pathology of the human pineal gland. Progress in Brain Research 1979; 52: 481–500
   PubMedGoogle Scholar
• Touitou Y., Bogdan A., Claustrat B., Touitou C. Drugs affecting melatonin secretion in man. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 349–356
   Google Scholar
• Trentini G. P., De Gaetani C. F., Criscuolo M., Migaldi M., Ferrari G. Pineal calcification in different physiopathological conditions in humans. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; vol 44: 291–304
   Google Scholar
• Vastine J. H., Kinney K. K. Pineal shadow as aid in localization of brain tumors. American Journal of Roentgenology & Radiation Therapy 1927; 17: 320–324
   Google Scholar
• Von Hungen K., Roberts S., Hill D. F. Interactions between lysergic-acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain. Brain Research 1975; 94: 57–61
   PubMed Web of Science ®Google Scholar
• Waldhauser F., Steger H. Changes in melatonin secretion with age and pubescence. Journal of Neural Transmission 1983; 272: 378–381, (supp)
   Google Scholar
• Waldhauser F., Steger H. Changes in melatonin secretion with age and pubescence. Journal of Neural Transmission 1986; 21: 183–197, (suppl)
   Google Scholar
• Waldhauser F., Weiszenbach G., Frisch H., Zeitlhuber U., Waldhauser M., Wurtman R. J. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet 1984; 1: 362–365
   PubMed Web of Science ®Google Scholar
• Weiner W. J., Goetz C, Klawans H. L. Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behavior. Acta Pharmacologica and Toxicologica 1975; 36: 155–161
   PubMedGoogle Scholar
• Weiner W., Werner I. Mania-induced remission of tardive dyskinesia in manic-depressive illness. Annals of Neurology 1982; 12: 229–230
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Arendt J., Paunier L., Sizonenko P. C., Van Donsellar W., Heyden T. Human serum melatonin changes during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1976; 42: 185–192
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Aperia B., Beck-Friis J. Melatonin and Cortisol levels in psychiatric illness. Lancet 1982; 2: 100
   PubMed Web of Science ®Google Scholar
• Wetterberg L. The relationship between the pineal gland and the pituitary-adrenal axis in health, endocrine and psychiatric conditions. Psychoneuroendocrinology 1983; 8: 75–80
   PubMed Web of Science ®Google Scholar
• Winblad B., Bucht G., Gottfries C. G., Roos B. E. Monoamines and monoamine metabolites in brains from demented schizophrenics. Acta Psychiatrica Scandinavica 1979; 60: 17–28
   PubMed Web of Science ®Google Scholar
• Wolf M. E., Almy G., Toll M., Mosnaim A. D. Mania associated with the use of baclofen. Biological Psychiatry 1982; 17: 757–759
   PubMed Web of Science ®Google Scholar
• Yassa R., Schwartz G. Depression as a predictor in the development of tardive dyskinesia. Biological Psychiatry 1984; 19: 411–444
   Web of Science ®Google Scholar
• Yassa R., Ghadirian A. M., Schwartz G. Prevalence of tardive dyskinesia in affective disorder patients. Journal of Clinical Psychiatry 1984; 44: 410–412
   Web of Science ®Google Scholar
• Yates C. A., Herbert J. Differential circadian rhythms in pineal and hypothalamic 5-HT induced by artificial photoperiods or melatonin. Nature 1976; 262: 219–220
   PubMed Web of Science ®Google Scholar
• Youssef H. A., Waddington J. L. Primitive (Developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: Overrepresentation in patients with tardive dyskinesia. Biological Psychiatry 1988; 23: 791–796
   PubMed Web of Science ®Google Scholar
• Zimmerman R. A., Bilaniuk L. T. Age-related incidence of pineal calcification detected by computed tomography. Neuroradiology 1982; 142: 659–662
   Google Scholar
• Zisapel N., Laudon M. Dopamine release induced by electrical field stimulation of rat hypothalamus in vitro inhibition by melatonin. Biochemistry Biophysics Research Communications 1982; 104: 1610–1616
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: Regional distribution in rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry. Brain Research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Nir I., Laudon M. Circadian variations in melatonin-binding sites in discrete areas of the male rat brain. FEBS Utters 1988; 232: 172–175
   PubMed Web of Science ®Google Scholar